The Ministry of Public Security, National Health Commission, and National Medical Products Administration in China have announced the inclusion of bromocaffeine, metonitazene, and etonitazene among a total of 46 substances in the Supplementary Catalogue of Controlled Varieties of Non-Medicinal Anesthetic Drugs and Psychotropic Drugs. This action is in accordance with the Regulations on the Control of Anesthetic and Psychoactive Drugs and Measures for the Administration of Non-Medicinal Anesthetic Drugs and Psychotropic Drugs. The updated regulations will take effect from July 1, 2024.- Flcube.com
Insight, China's Pharmaceutical Industry
Fineline Insights, Pharma Clarity